0% of $100,000 goal
Burn survivors often face a lifetime of stigma and rejection due to their injury disability, disfigurement, or prolonged hospitalization to treat and care for their injuries. At present, no skin substitute or available therapy exists that replaces all of the characteristics of healthy human skin needed in the treatment of severe burns.
Since 2016, we have been developing realSKIN® , our first biotherapy indicated for the treatment of severe burns. We are performing a 10-patient proof of concept clinical study that will bring this product one step closer to market approval and provide benefit to countless patients in the future.
XenoTherapeutics is a not-for-profit research organization passionate about delivering new biotherapies that restore people’s quality of life.
Live cell biotherapies have changed the way we look at treatments for ailments and injuries. By allowing the body to replace its damaged cells and tissues with healthy, functioning cells, our bodies can heal themselves naturally. This process is vitally important to maintaining health and keeping us alive, as our bodies inevitably wear down due to illness, age, and injury.
We understand the critical needs of a growing global population. That is why we are dedicated to accelerating the testing, development, training, and commercialization of innovative, live biotherapeutic products to ensure that there will always be a sufficient supply to meet the true demand of the population.
Find out more about XenoTherapeutics Foundation: https://www.xenotx.org/